| Count |
Word |
| 1.820 |
altered |
| 1.821 |
antagonist |
| 1.964 |
approaches |
| 4.004 |
autoimmune |
| 7.469 |
cd46 |
| 0.664 |
cell |
| 1.393 |
central |
| 1.155 |
chronic |
| 2.135 |
cns |
| 1.242 |
complex |
| 3.141 |
costimulatory |
| 1.837 |
cytoplasmic |
| 1.308 |
developed |
| 1.455 |
differentiation |
| 1.618 |
disease |
| 2.975 |
eae |
| 0.585 |
effects |
| 2.753 |
encephalomyelitis |
| 2.094 |
exhibit |
| 1.303 |
experimental |
| 0.904 |
expression |
| 2.465 |
il-10 |
| 3.819 |
il-17 |
| 0.933 |
increased |
| 1.957 |
induces |
| 3.622 |
inflammation |
| 2.082 |
isoforms |
| 2.375 |
model |
| 1.865 |
molecule |
| 1.433 |
mouse |
|
| Count |
Word |
| 4.522 |
ms |
| 1.343 |
multiple |
| 1.819 |
murine |
| 1.656 |
need |
| 1.561 |
nervous |
| 1.035 |
observed |
| 0.562 |
patients |
| 1.682 |
phenotype |
| 1.815 |
potent |
| 3.116 |
pro-inflammatory |
| 1.322 |
production |
| 3.656 |
regulatory |
| 2.008 |
sclerosis |
| 0.953 |
system |
| 2.311 |
tail |
| 2.590 |
th1 |
| 4.277 |
tr1 |
| 2.198 |
treating |
|